Effect of ezetimibe on major atherosclerotic disease events and all-cause mortality

American Journal of Cardiology

Volumn 111, Issue 4, 2013, Pages 532-539

  Hayek, Sami ^a   Canepa Escaro, Fabrizio ^a   Sattar, Assad ^a   Gamalski, Steven ^a   Wells, Karen E ^a   Divine, George ^a   Ahmedani, Brian K ^a   Lanfear, David E ^a   Pladevall, Manel ^b   Williams, L Keoki ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b RTI HEALTH SOLUTIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; ATHEROSCLEROSIS; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG INFORMATION; DRUG UTILIZATION; ETHNICITY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RACE DIFFERENCE; TREATMENT OUTCOME;

ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; AZETIDINES; CAUSE OF DEATH; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MICHIGAN; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES;

EID: 84873304439     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.11.002     Document Type: Article

References (30)

1. J.L. Fleg, M. Mete, B.V. Howard, J.G. Umans, M.J. Roman, R.E. Ratner, A. Silverman, J.M. Galloway, J.A. Henderson, M.R. Weir, C. Wilson, M. Stylianou, and W.J. Howard Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial J Am Coll Cardiol 52 2008 2198 2205
2. J.J. Kastelein, F. Akdim, E.S. Stroes, A.H. Zwinderman, M.L. Bots, A.F. Stalenhoef, F.L. Visseren, E.J. Sijbrands, M.D. Trip, E.A. Stein, D. Gaudet, R. Duivenvoorden, E.P. Veltri, A.D. Marais, and G.E. de Simvastatin with or without ezetimibe in familial hypercholesterolemia N Engl J Med 358 2008 1431 1443
3. A.J. Taylor, T.C. Villines, E.J. Stanek, P.J. Devine, L. Griffen, M. Miller, N.J. Weissman, and M. Turco Extended-release niacin or ezetimibe and carotid intima-media thickness N Engl J Med 361 2009 2113 2122
4. C. Baigent, M.J. Landray, C. Reith, J. Emberson, D.C. Wheeler, C. Tomson, C. Wanner, V. Krane, A. Cass, J. Craig, B. Neal, L. Jiang, L.S. Hooi, A. Levin, L. Agodoa, M. Gaziano, B. Kasiske, R. Walker, Z.A. Massy, B. Feldt-Rasmussen, U. Krairittichai, V. Ophascharoensuk, B. Fellstrom, H. Holdaas, V. Tesar, A. Wiecek, D. Grobbee, Z.D. de, C. Gronhagen-Riska, T. Dasgupta, D. Lewis, W. Herrington, M. Mafham, W. Majoni, K. Wallendszus, R. Grimm, T. Pedersen, J. Tobert, J. Armitage, A. Baxter, C. Bray, Y. Chen, Z. Chen, M. Hill, C. Knott, S. Parish, D. Simpson, P. Sleight, A. Young, and R. Collins The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 377 2011 2181 2192
5. Z.A. Habib, L. Tzogias, S.L. Havstad, K. Wells, G. Divine, D.E. Lanfear, J. Tang, R. Krajenta, M. Pladevall, and L.K. Williams Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis Pharmacoepidemiol Drug Saf 18 2009 437 447
6. K.E. Wells, E.L. Peterson, B.K. Ahmedani, R.K. Severson, J. Gleason-Comstock, and L.K. Williams The relationship between combination inhaled corticosteroid and long-acting beta-agonist use and severe asthma exacerbations in a diverse population J Allergy Clin Immunol 129 2012 1274 1279
7. N. Singer Study raises questions about cholesterol drug's benefit The New York Times November 16, 2009 A16
8. J.F. Steiner, and A.V. Prochazka The assessment of refill compliance using pharmacy records: methods, validity, and applications J Clin Epidemiol 50 1997 105 116
9. L.K. Williams, C.L. Joseph, E.L. Peterson, K. Wells, M. Wang, V.K. Chowdhry, M. Walsh, J. Campbell, C.S. Rand, A.J. Apter, D.E. Lanfear, K. Tunceli, and M. Pladevall Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence J Allergy Clin Immunol 120 2007 1153 1159
10. T.C. Weng, Y.H. Yang, S.J. Lin, and S.H. Tai A systematic review and meta-analysis on the therapeutic equivalence of statins J Clin Pharm Ther 35 2010 139 151
11. J. Coresh, B.C. Astor, T. Greene, G. Eknoyan, and A.S. Levey Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey Am J Kidney Dis 41 2003 1 12
12. P.D. Allison Discrete-time methods for the analysis of event histories Sociol Methodol 13 1982 61 98
13. P.D. Allison Analysis of tied or discrete data with the LOGISTIC, PROBIT, and GENMOD procedures Survival Analysis Using the SAS System: A Practical Guide 1995 SAS Institute Inc. Cary, North Carolina 211 231
14. SAS Institute Inc SAS/STAT Users Guide. Version 9.2 ed 2008 SAS Institute Inc. Cary, North Carolina
15. R.G. O'Brien Using the SAS system to perform power analyses for log-linear models Proceedings of the Eleventh Annual SAS Users Group International Conference 1986 SAS Institute Inc. Cary, North Carolina 778 782
16. G. Divine, A. Kapke, S. Havstad, and C.L. Joseph Exemplary data set sample size calculation for Wilcoxon-Mann-Whitney tests Stat Med 29 2010 108 115
17. J.R. Downs, M. Clearfield, S. Weis, E. Whitney, D.R. Shapiro, P.A. Beere, A. Langendorfer, E.A. Stein, W. Kruyer, and A.M. Gotto Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS JAMA 279 1998 1615 1622
18. J. Shepherd, S.M. Cobbe, I. Ford, C.G. Isles, A.R. Lorimer, P.W. MacFarlane, J.H. McKillop, C.J. Packard West of Scotland Coronary Prevention Study Group Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301 1307
19. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
20. F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, T.G. Cole, L. Brown, J.W. Warnica, J.M. Arnold, C.C. Wun, B.R. Davis, E. Braunwald Cholesterol and Recurrent Events Trial Investigators The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1996 1001 1009
21. J.C. LaRosa, S.M. Grundy, D.D. Waters, C. Shear, P. Barter, J.C. Fruchart, A.M. Gotto, H. Greten, J.J. Kastelein, J. Shepherd, and N.K. Wenger Intensive lipid lowering with atorvastatin in patients with stable coronary disease N Engl J Med 352 2005 1425 1435
22. T.R. Pedersen, O. Faergeman, J.J. Kastelein, A.G. Olsson, M.J. Tikkanen, I. Holme, M.L. Larsen, F.S. Bendiksen, C. Lindahl, M. Szarek, and J. Tsai High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial JAMA 294 2005 2437 2445
23. E.A. Stein Additional lipid lowering trials using surrogate measurements of atherosclerosis by carotid intima-media thickness: more clarity or confusion? J Am Coll Cardiol 52 2008 2206 2209
24. U. Khanderia, R.E. Regal, M. Rubenfire, and T. Boyden The ezetimibe controversy: implications for clinical practice Ther Adv Cardiovasc Dis 5 2011 199 208
25. Z.D. Goldberger, J.A. Valle, V.K. Dandekar, P.S. Chan, D.T. Ko, and B.K. Nallamothu Are changes in carotid intima-media thickness related to risk of nonfatal myocardial infarction? A critical review and meta-regression analysis Am Heart J 160 2010 701 714
26. P. Costanzo, P. Perrone-Filardi, E. Vassallo, S. Paolillo, P. Cesarano, G. Brevetti, and M. Chiariello Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials J Am Coll Cardiol 56 2010 2006 2020
27. M.W. Lorenz, J.F. Polak, M. Kavousi, E.B. Mathiesen, H. Volzke, T.P. Tuomainen, D. Sander, M. Plichart, A.L. Catapano, C.M. Robertson, S. Kiechl, T. Rundek, M. Desvarieux, L. Lind, C. Schmid, P. DasMahapatra, L. Gao, K. Ziegelbauer, M.L. Bots, and S.G. Thompson Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data Lancet 379 2012 2053 2062
28. D. Morrone, W.S. Weintraub, P.P. Toth, M.E. Hanson, R.S. Lowe, J. Lin, A.K. Shah, and A.M. Tershakovec Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials Atherosclerosis 223 2012 251 261
29. R.J. Glynn, S. Schneeweiss, and T. Sturmer Indications for propensity scores and review of their use in pharmacoepidemiology Basic Clin Pharmacol Toxicol 98 2006 253 259
30. M.M. Joffe, and P.R. Rosenbaum Invited commentary: propensity scores Am J Epidemiol 150 1999 327 333